COL5A1 and glioblastoma: KM analyses illustrated that patients with ACC (Figure 6(b), p = 0.034), GBM (Figure 6(c), p = 0.009), KIRC (Figure 6(d), p < 0.001), KIRP (Figure 6(e), p < 0.001), LGG (Figure 6(f), p = 0.006), MESO (Figure 6(g), p = 0.006), PRAD (Figure 6(h), p = 0.024), and UVM (Figure 6(i), p = 0.002) who exhibited low expression of COL5A1 had longer survival time.